GlassScriptPhysician profile
David J Kickliter
NPI 1609850569
$7,120.56
in general payments reported to CMS, 2019-2025
43 companies · $23.17 in 2025
The $23.17 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,954 · 2020: $1,501 · 2021: $2,021 · 2022: $1,420 · 2023: $201 · 2025: $23.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,508.38 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $603.80 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $567.28 | 2019-2023 | Fasenra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $526.04 | 2019-2022 | |
| Abbvie INC. | $359.65 | 2019-2022 | |
| Pfizer INC. | $332.36 | 2019-2023 | |
| Amarin Pharma, INC. | $311.18 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $310.39 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $295.39 | 2019-2023 | |
| Amgen INC. | $263.16 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $216.14 | 2019-2023 | Xarelto |
| Astellas Pharma US INC | $173.50 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $169.42 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.19 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $132.83 | 2019-2023 | Eliquis |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kickliter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.